Health
What’s the Valneva COVID-19 vaccine, the French shot that’s supposed to be ‘variant proof’? – The Conversation AU
It sounds too good to be true, a vaccine that can protect against future virus variants. But governments around the world are keen to learn more.
A COVID-19 vaccine from French company Valneva has yet to complete clinical trials. But it has caught the eye of governments in the UK, Europe and Australia.
One of the vaccines main selling points is its apparent ability to mount a more general immune response against SARS-CoV-2, the virus that causes COVID-19, rather than rely on the spike protein to do this.
This means the vaccine is more likely to be effective against the type of virus variants weve already seen emerging, and may emerge in…
-
Business15 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
General24 hours agoLiberals dump NSW candidate who said women should not serve in ADF combat
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts